Zoonotic Diseases and Public Health · Journal article
Pathogens · September 7, 2026
A consensus or society position rather than new primary data.
This narrative review confirms the zoonotic potential of Brucella canis but notes that the true burden of human infection remains uncertain due to nonspecific clinical presentation, limited diagnostic availability, and insufficient professional awareness. The authors recommend improved clinical recognition, strengthened veterinary–human health collaboration, expanded access to standardized diagnostics, and integrated One Health surveillance to reduce zoonotic risk.
Narrative review. Published human cases, laboratory-acquired infections, household clusters, and cases across different age and immune-status groups; canine infection epidemiology and transmission characteristics..
B. canis is a recognized zoonotic pathogen associated with human infection across various epidemiological settings. Unlike classical brucellosis caused by smooth Brucella species, B. canis infection may be overlooked, potentially leading to delayed diagnosis and incomplete case detection. Available evidence confirms zoonotic potential of B. canis but remains insufficient to define the true burden of human infection.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians, veterinarians, microbiologists, and public health professionals should heighten awareness of B. canis as a potential zoonotic pathogen and maintain clinical suspicion in cases with nonspecific presentation and exposure history. Improving diagnostic capacity and intersectoral collaboration is essential to reduce diagnostic delay and case underdetection.
A narrative review synthesizing evidence on epidemiology, diagnostics, and public health implications of B. canis infection, identifying knowledge gaps and recommending improvements to clinical awareness and surveillance.
As stated by the source record.
Clinicians, veterinarians, microbiologists, and public health professionals should heighten awareness of B. canis as a potential zoonotic pathogen and maintain clinical suspicion in cases with nonspecific presentation and exposure history. Improving diagnostic capacity and intersectoral collaboration is essential to reduce diagnostic delay and case underdetection.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Brucella canis is a recognized zoonotic pathogen associated with human infection in a variety of epidemiological settings; however, the magnitude of its impact on human health remains uncertain because of its nonspecific clinical presentation, limited availability of species-specific diagnostic methods, and insufficient awareness among physicians, veterinarians, microbiologists, and public health professionals. Unlike classical human brucellosis caused by smooth Brucella species, B. canis infection may be overlooked, potentially leading to delayed diagnosis and incomplete case detection. This narrative review summarizes current evidence on the epidemiology, transmission pathways, occupational and non-occupational risk factors, clinical manifestations, diagnostic approaches, treatment, and public health implications of human B. canis infection. Particular emphasis is placed on published human cases, laboratory-acquired infections, household clusters, cases reported in different age and immune-status groups, and the biological and epidemiological characteristics of canine infection that facilitate zoonotic transmission. The review further examines the limitations of currently available microbiological, serological, and molecular diagnostic methods, the lack of harmonized surveillance systems, and the consequences of inadequate recognition from a One Health perspective. Collectively, the available evidence confirms the zoonotic potential of B. canis but remains insufficient to define the true burden of human infection. Improving clinical awareness, strengthening collaboration between veterinary and human health sectors, expanding access to standardized diagnostic tools, and implementing integrated One Health surveillance may improve recognition and reduce zoonotic risk.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.